Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Clinical trial NCT05764928 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05764928
Sponsor: Rgene Corporation
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nonsquamous Nonsmall Cell Neoplasm of Lung

Start date: 2026-12-01
Primary completion: 2027-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.